Question 1

How much would I have if I DCA'd $100/week into NUVB for 5 years?

Accepted Answer

Dollar cost averaging $100 per week into NUVB for 5 years (261 purchases) would have resulted in a total investment of $26,100 and a current value of $49,022, a return of 88%. Using Enhanced DCA, which concentrates buys during dips, the same $100/week base deployed $57,198 and grew to $120,418 — a 111% return.

Question 2

What is the best DCA strategy for NUVB?

Accepted Answer

Backtesting shows Enhanced DCA — which increases buy amounts during market dips and reduces or skips buys when NUVB is overextended — outperformed standard weekly DCA by 23% over 5 years. The enhanced strategy achieved a 111% return vs 88% for standard DCA.

Question 3

What would $100/week into NUVB be worth after 3 years?

Accepted Answer

Investing $100 per week into NUVB for 3 years (157 purchases, $15,700 total) would have grown to $28,677 — a 83% return. Enhanced DCA over the same period returned 122%.

Question 4

Is DCA into NUVB worth it?

Accepted Answer

Based on a 5-year backtest, DCA into NUVB returned 88% with standard weekly purchases. An intelligent DCA strategy that buys more during dips returned 111% over the same period — a 23% gain in return, while deploying more capital.

Question 5

How many shares of NUVB would I have after DCA for 5 years?

Accepted Answer

Dollar cost averaging $100/week into NUVB for 5 years would result in approximately 9804 shares with a standard DCA approach (avg entry $3). Enhanced DCA targeting dips results in 24084 shares at an average entry of $2.

Question 6

How does NUVB DCA compare to the S&P 500?

Accepted Answer

Enhanced DCA into NUVB returned 111% over the past 5 years. The S&P 500 (SPY) returned approximately 53% over the same period. NUVB's performance reflects its volatility as a healthcare asset. Enhanced DCA outperformed standard DCA by 23%, demonstrating the value of intelligent entry timing during market dips.

Question 7

What is the risk of dollar cost averaging into NUVB?

Accepted Answer

Past backtest performance does not guarantee future results. NUVB is a healthcare asset whose price can fall as well as rise. While DCA reduces timing risk by spreading purchases over time, losses are still possible if the price declines significantly. Always invest within your risk tolerance and consider your overall portfolio diversification.

Question 8

What is the Nuvation Bio Inc. dollar cost averaging strategy?

Accepted Answer

Standard DCA invests a fixed amount ($100/week or $433/month) into NUVB at regular intervals. Enhanced DCA improves on this by using RSI (Relative Strength Index) signals to increase buy amounts during market dips (oversold conditions) and reduce or skip purchases when the stock is overextended. Over the 5-year backtest, this timing approach has delivered 23% higher returns than standard DCA while deploying more total capital into NUVB.

Period	Standard DCA	Enhanced DCA	Alpha
1-Year	-9%	7%	+16%
3-Year	83%	122%	+39%
5-Year	88%	111%	+23%

NUVB DCA Backtest — Dollar Cost Averaging Results

NUVB DCA Results: Key Findings

Alpha you missed while unsubscribed

Dollar cost averaging into NUVB — backtest results

Buying the dips for Nuvation Bio Inc.